Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medtecs International's yield on cost for the quarter that ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Medtecs International's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Medtecs International's highest Yield on Cost was 52.29. The lowest was 0.00. And the median was 5.76.
TPE:9103's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.36 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Medtecs International (TPE:9103) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medtecs International 5-Year Yield-on-Cost % Related Terms
TPE:9103 vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Medtecs International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtecs International 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtecs International's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medtecs International's 5-Year Yield-on-Cost % falls into.
Medtecs International 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Medtecs International (TPE:9103) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 14, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medtecs International and its competitors. According to the industry distribution chart, Medtecs International ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Medtecs International's 5-Year Yield-on-Cost % too high?
Medtecs International's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Medtecs International ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medtecs International has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medtecs International's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medtecs International ranks #999999 out of 316 companies for 5-Year Yield-on-Cost %. This places Medtecs International in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.36, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medtecs International and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtecs International's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtecs International stock overvalued right now?
Based on GuruFocus' analysis, Medtecs International (TPE:9103) is currently considered Possible Value Trap. The stock's GF Value™ is NT$7.67, compared to a current price of NT$5.12 — trading 33.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Medtecs International's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medtecs International (TPE:9103), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtecs International (TPE:9103) Overvalued in 2026?
Based on GuruFocus' analysis, Medtecs International stock appears to be undervalued.
The current stock price of NT$5.12 is trading 33.2% below its estimated GF Value™ of NT$7.67.
GuruFocus considers Medtecs International to be Possible Value Trap.
Key valuation signals for TPE:9103:
5-Year Yield-on-Cost %: 0.00
GF Value™: NT$7.67 vs. price of NT$5.12 (33.2% below fair value)
No single metric tells the full story. See the TPE:9103 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medtecs International Corp Ltd is an investment holding company. The company, along with its subsidiaries, is a manufacturer of medical consumables and provides healthcare products and services. It operates in three segments. The Manufacturing segment produces and sub-contracts medical consumables, including patients' apparel, disposable surgical masks, boot covers and surgical gowns, adult diapers, underpads, crochet blankets, bed linens and medical bandages. The Hospital services segment provides laundry and leasing services. The Distribution segment is involved in the marketing of Medtecs-branded medical consumables to hospitals, pharmacies, and other end users in Asia Pacific and through online channels. It generates the majority of its revenue from the Manufacturing segment.
70GF Score
Get the complete analysis for TPE:9103
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:9103 has been successfully added to your 
